Gemini Bio
About Gemini Bio
Gemini Bio is a company based in West Sacramento (United States) founded in 1985 was acquired by BelHealth Investment Partners in September 2018.. Gemini Bio has raised $5.68 million across 2 funding rounds from investors including Broadoak Capital Partners and BelHealth Investment Partners. The company has 79 employees as of December 31, 2022. Gemini Bio has completed 1 acquisition, including Orflo. Gemini Bio operates in a competitive market with competitors including MaxCyte, SQZBiotech, Fluxion Biosciences, Berkeley Lights and LBT Innovations, among others.
- Headquarter West Sacramento, United States
- Employees 79 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.68 M (USD)
in 2 rounds
-
Latest Funding Round
$5.68 M (USD), Unspecified
May 10, 2024
-
Investors
Broadoak Capital Partners
& 1 more
-
Employee Count
79
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
BelHealth Investment Partners
(Sep 14, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Gemini Bio
Gemini Bio has successfully raised a total of $5.68M across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $5.68 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Unspecified — $5.7M
-
First Round
First Round
(17 Nov 2021)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Unspecified - Gemini Bio | Valuation |
investors |
|
| Nov, 2021 | Amount | Debt – Conventional - Gemini Bio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Gemini Bio
Gemini Bio has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Broadoak Capital Partners and BelHealth Investment Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in healthcare businesses, focusing on services, products, and distribution.
|
Founded Year | Domain | Location | |
|
Investment banking services are offered in the United States.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gemini Bio
Gemini Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Orflo. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Instrumentation for cell and protein analysis is developed and marketed.
|
2003 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Gemini Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gemini Bio Comparisons
Competitors of Gemini Bio
Gemini Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MaxCyte, SQZBiotech, Fluxion Biosciences, Berkeley Lights and LBT Innovations, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instrument systems for cell processing and modification are provided.
|
|
| domain | founded_year | HQ Location |
Cell therapies are developed using proprietary Cell Squeeze technology.
|
|
| domain | founded_year | HQ Location |
Microfluidics-based tools for cellular analysis are provided.
|
|
| domain | founded_year | HQ Location |
Microfluidics-based systems for single-cell isolation and analysis are developed.
|
|
| domain | founded_year | HQ Location |
Developer of AI-based automated solutions for the preparation and analysis of microbiology culture specimens
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gemini Bio
Frequently Asked Questions about Gemini Bio
When was Gemini Bio founded?
Gemini Bio was founded in 1985 and raised its 1st funding round 36 years after it was founded.
Where is Gemini Bio located?
Gemini Bio is headquartered in West Sacramento, United States. It is registered at West Sacramento, California, United States.
Who is the current CEO of Gemini Bio?
Brian Parker is the current CEO of Gemini Bio.
Is Gemini Bio a funded company?
Gemini Bio is a funded company, having raised a total of $5.68M across 2 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $18.5M, raised on Nov 17, 2021.
How many employees does Gemini Bio have?
As of Dec 31, 2022, the latest employee count at Gemini Bio is 79.
What does Gemini Bio do?
Gemini Bio was established in 1985 in West Sacramento, United States. Custom media, animal and human sera, buffers, and other supplement reagents are produced by the company for use in academic research, biotechnology, cell and gene therapy, and biopharma sectors. These materials are distributed to scientific communities worldwide to support research and development activities in life sciences.
Who are the top competitors of Gemini Bio?
Gemini Bio's top competitors include MaxCyte, SQZBiotech and Mytos.
How many acquisitions has Gemini Bio made?
Gemini Bio has made 1 acquisition, including Orflo.
Who are Gemini Bio's investors?
Gemini Bio has 2 investors. Key investors include Broadoak Capital Partners, and BelHealth Investment Partners.